We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Our Commitment to Treating Influenza

Our Commitment to Treating Influenza

Influenza season is fast approaching and it continues to be a threat to public health. We remain dedicated to preventing infections and hospitalizations from influenza. Read our latest update about how we’re tackling influenza.